Benesch Joseph 4
4 · Journey Medical Corp · Filed Apr 24, 2026
Research Summary
AI-generated summary of this filing
Journey Medical (DERM) CFO Benesch Receives RSUs & Options
What Happened
Joseph Benesch, Chief Financial Officer of Journey Medical Corp (DERM), received equity awards on April 22, 2026: 28,907 restricted stock units (RSUs) and 41,860 stock options. Both transactions are reported as awards (code A) with $0.00 cash paid at grant; the RSUs and options vest over three years per the footnotes.
Key Details
- Transaction date: April 22, 2026; Form 4 filed April 24, 2026 (appears timely).
- Awards: 28,907 RSUs (reported acquisition value $0.00) and 41,860 stock options (reported $0.00).
- Vesting schedule (per filing footnotes):
- RSUs: 9,636 shares vest on Apr 22, 2027; 9,636 on Apr 22, 2028; 9,635 on Apr 22, 2029.
- Options: 13,953 options vest on Apr 22, 2027; 13,953 on Apr 22, 2028; 13,954 on Apr 22, 2029.
- Post-transaction share ownership: not specified in the provided filing excerpt.
- Transaction codes: A = award/grant; includes derivative award (options) as noted.
- No indication in the filing that the awards were part of a 10b5-1 plan, a gift, or a cashless exercise.
Context
These are compensation grants—not purchases or sales. RSUs convert to shares upon vesting; options give the right to buy shares at their exercise price (exercise price not provided in the excerpt). Such grants are routine long-term incentive awards and do not, by themselves, represent a market purchase or sale.
Insider Transaction Report
- Award
Common Stock, $0.0001 par value
[F1][F2]2026-04-22+28,907→ 261,371 total - Award
Stock Option (Right to Buy)
[F3]2026-04-22+41,860→ 41,860 totalExercise: $5.04Exp: 2036-04-22→ Common Stock, $0.0001 par value (41,860 underlying)
Footnotes (3)
- [F1]On April 22, 2026, the reporting person was granted 28,907 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, that will vest in accordance with the following schedule: 9,636 shares on April 22, 2027, 9,636 shares on April 22, 2028 and 9,635 shares on April 22, 2029.
- [F2]Includes restricted stock units, which vest over various time periods.
- [F3]On April 22, 2026, the reporting person was granted 41,860 stock options pursuant to the Issuer's 2015 Stock Plan, as amended, that will vest in accordance with the following schedule: 13,953 shares on April 22, 2027, 13,953 shares on April 22, 2028 and 13,954 shares on April 22, 2029.